-+ 0.00%
-+ 0.00%
-+ 0.00%

B. Riley Securities Downgrades Anterix to Neutral, Raises Price Target to $69

Benzinga·06/04/2026 13:33:04
Listen to the news
B. Riley Securities analyst Mike Crawford downgrades Anterix (NASDAQ:ATEX) from Buy to Neutral and raises the price target from $44 to $69.